Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 29 September 2006:
Vol. 313. no. 5795, p. 1855
DOI: 10.1126/science.313.5795.1855a

Editors' Choice: Highlights of the recent literature

The rollout of antiretroviral therapy during 2004-2008 in South Africa brings with it severe ethical dilemmas regarding the allocation of drugs, because supply will outstrip need. Incorporating data from KwaZulu-Natal in a spatially explicit mathematical model, Wilson et al. have applied the government's allocation strategy in three scenarios to predict the consequences of different choices.

The modeling reveals clearly that for preventing transmission, the most effective strategy is to concentrate all of the doses (for half a million people living with HIV) in Durban, where HIV prevalence is 13%. This will have the effect of preventing 15,000 infections by 2008, minimizing the transmission of drug resistance, and preventing the greatest number of deaths. But this choice is not egalitarian, and the intent of antiretroviral therapy is treatment and not prevention. However, if the drug allocation were split between urban and rural areas (just over half of the KwaZulu-Natal population is rural, with an HIV prevalence of 9%), its effectiveness for HIV prevention would be reduced by about a third to a half, not just because the rural population is dispersed but also because the rural health infrastructure is relatively weak and because distribution and clinical monitoring will not be so effective. -- CA

Proc. Natl. Acad. Sci. U.S.A. 103, 14228 (2006)






To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)